SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001610618-21-000037
Filing Date
2021-04-28
Accepted
2021-04-28 16:07:15
Documents
4
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT cdtxdef14a2021.htm DEF 14A 510813
2 cdtx_proxycardxpg011a.jpg GRAPHIC 1466917
3 cdtx_proxycardxpg021a.jpg GRAPHIC 1131416
4 cdtxlogoa131a.jpg GRAPHIC 46741
  Complete submission text file 0001610618-21-000037.txt   4145602
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36912 | Film No.: 21864256
SIC: 2836 Biological Products, (No Diagnostic Substances)